Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACHIEVE GREATER Project 2: Early Prevention of Heart Failure
NCT05330221Active, not recruiting
- Sponsor
- Henry Ford Health
- Start
- Jan 2023
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in heart failure (HF) and hypertension (HTN) (2 arms), sponsored by Henry Ford Health. Primary endpoints: Systolic blood pressure at 12 months and NT-proB-type Natriuretic Peptide at 12 months. Started Jan 2023; status: active, not recruiting.
02
Conditions
heart failure (HF)hypertension (HTN)
Beyond the preview
Go deeper on NCT05330221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05330221.